Ethyl (Z)-6-(2-bromoacetyl)oxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]hex-4-enoate
C15H24BrNO6 — CID 134834927
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl (Z)-6-(2-bromoacetyl)oxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]hex-4-enoate
Ethyl (Z)-6-(2-bromoacetyl)oxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]hex-4-enoate (PubChem CID 134834927) has the molecular formula C15H24BrNO6 and a molecular weight of 394.26 g/mol. Its IUPAC name is ethyl (Z)-6-(2-bromoacetyl)oxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]hex-4-enoate.
Molecular Properties
| Compound Name | Ethyl (Z)-6-(2-bromoacetyl)oxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]hex-4-enoate |
|---|---|
| PubChem CID | 134834927 |
| Molecular Formula | C15H24BrNO6 |
| Molecular Weight | 394.26 g/mol |
| Exact Mass | 393.08 |
| IUPAC Name | ethyl (Z)-6-(2-bromoacetyl)oxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]hex-4-enoate |
| SMILES | CCOC(=O)C(C/C=C\COC(=O)CBr)NC(=O)OC(C)(C)C |
| InChI | InChI=1S/C15H24BrNO6/c1-5-21-13(19)11(17-14(20)23-15(2,3)4)8-6-7-9-22-12(18)10-16/h6-7,11H,5,8-10H2,1-4H3,(H,17,20)/b7-6- |
| InChIKey | CUSDOPOHMUXWAO-SREVYHEPSA-N |
| XLogP | 2.33 |
| TPSA | 90.93 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 394.26 |
| LogP ≤ 5 | 2.33 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134834927 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.